GlassScriptPhysician profile
John K Wolcott
NPI 1396740064
$2,582.46
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $611 · 2021: $397 · 2022: $351 · 2023: $491 · 2024: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $410.63 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $353.99 | 2019-2022 | |
| Novo Nordisk INC | $292.85 | 2019-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $259.21 | 2019-2024 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $222.79 | 2019-2024 | Trelegy Ellipta |
| Amgen INC. | $198.48 | 2020-2024 | Repatha, Otezla |
| Lilly USA, LLC | $188.00 | 2019-2024 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $180.25 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.78 | 2020-2023 | Xifaxan |
| Pfizer INC. | $94.38 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $69.40 | 2023-2024 | Quviviq |
| Abbvie INC. | $56.21 | 2021-2024 | Linzess, Viberzi |
| Harmony Biosciences LLC | $32.81 | 2023 | Wakix |
| Allergan, INC. | $28.95 | 2020 | |
| Eisai INC. | $20.98 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16.99 | 2023 | Veozah |
| Janssen Pharmaceuticals, INC | $16.62 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.93 | 2020 | |
| Currax Pharmaceuticals LLC | $12.72 | 2022 | |
| Supernus Pharmaceuticals, INC. | $11.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wolcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.